世界の静脈内（IV）鉄剤市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Intravenous (IV) Iron Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z07859 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、静脈内（IV）鉄剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。静脈内（IV）鉄剤の種類別市場規模（カルボキシマルトース鉄、鉄スクロース、鉄デキストラン、その他）、用途別市場規模（腎臓、婦人科・産科、消化器病、腫瘍、心臓病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・静脈内（IV）鉄剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi US、Allergan、AMAG Pharmaceuticals、Dalichi Sankyo、Luitpold Pharmaceuticals、Pharmacosmos、Takeda Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：カルボキシマルトース鉄、鉄スクロース、鉄デキストラン、その他 ・用途別分析2016年-2026年：腎臓、婦人科・産科、消化器病、腫瘍、心臓病、その他 ・静脈内（IV）鉄剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・静脈内（IV）鉄剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・静脈内（IV）鉄剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・静脈内（IV）鉄剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・静脈内（IV）鉄剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Intravenous (IV) Iron Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Intravenous (IV) Iron Drugs size is estimated to be xx million in 2020 from USD 1472.2 million in 2019, with a change of XX% between 2019 and 2020. The global Intravenous (IV) Iron Drugs market size is expected to grow at a CAGR of 3.9% for the next five years.

Market segmentation
Intravenous (IV) Iron Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others

Market segment by Application can be divided into
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others

The key market players for global Intravenous (IV) Iron Drugs market are listed below:
Sanofi US
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Intravenous (IV) Iron Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous (IV) Iron Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ferric Carboxymaltose
1.2.3 Iron Sucrose
1.2.4 Iron Dextran
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous (IV) Iron Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Global Intravenous (IV) Iron Drugs Market Size & Forecast
1.4.1 Global Intravenous (IV) Iron Drugs Sales in Value (2016-2026))
1.4.2 Global Intravenous (IV) Iron Drugs Sales in Volume (2016-2026)
1.4.3 Global Intravenous (IV) Iron Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Intravenous (IV) Iron Drugs Production Capacity Analysis
1.5.1 Global Intravenous (IV) Iron Drugs Total Production Capacity (2016-2026)
1.5.2 Global Intravenous (IV) Iron Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous (IV) Iron Drugs Market Drivers
1.6.2 Intravenous (IV) Iron Drugs Market Restraints
1.6.3 Intravenous (IV) Iron Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi US
2.1.1 Sanofi US Details
2.1.2 Sanofi US Major Business
2.1.3 Sanofi US Intravenous (IV) Iron Drugs Product and Services
2.1.4 Sanofi US Intravenous (IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Intravenous (IV) Iron Drugs Product and Services
2.2.4 Allergan Intravenous (IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 AMAG Pharmaceuticals
2.3.1 AMAG Pharmaceuticals Details
2.3.2 AMAG Pharmaceuticals Major Business
2.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product and Services
2.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Dalichi Sankyo
2.4.1 Dalichi Sankyo Details
2.4.2 Dalichi Sankyo Major Business
2.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Product and Services
2.4.4 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Luitpold Pharmaceuticals
2.5.1 Luitpold Pharmaceuticals Details
2.5.2 Luitpold Pharmaceuticals Major Business
2.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product and Services
2.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pharmacosmos
2.6.1 Pharmacosmos Details
2.6.2 Pharmacosmos Major Business
2.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Product and Services
2.6.4 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Takeda Pharmaceutical
2.7.1 Takeda Pharmaceutical Details
2.7.2 Takeda Pharmaceutical Major Business
2.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product and Services
2.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Intravenous (IV) Iron Drugs Sales by Manufacturer
3.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Intravenous (IV) Iron Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Intravenous (IV) Iron Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous (IV) Iron Drugs Manufacturer Market Share
3.4.2 Top 6 Intravenous (IV) Iron Drugs Manufacturer Market Share
3.5 Global Intravenous (IV) Iron Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Intravenous (IV) Iron Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous (IV) Iron Drugs Market Size by Region
4.1.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Intravenous (IV) Iron Drugs Revenue by Region (2016-2026)
4.2 North America Intravenous (IV) Iron Drugs Revenue (2016-2026)
4.3 Europe Intravenous (IV) Iron Drugs Revenue (2016-2026)
4.4 Asia-Pacific Intravenous (IV) Iron Drugs Revenue (2016-2026)
4.5 South America Intravenous (IV) Iron Drugs Revenue (2016-2026)
4.6 Middle East and Africa Intravenous (IV) Iron Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Type (2016-2026)
5.2 Global Intravenous (IV) Iron Drugs Revenue by Type (2016-2026)
5.3 Global Intravenous (IV) Iron Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Application (2016-2026)
6.2 Global Intravenous (IV) Iron Drugs Revenue by Application (2016-2026)
6.3 Global Intravenous (IV) Iron Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous (IV) Iron Drugs Sales by Type (2016-2026)
7.2 North America Intravenous (IV) Iron Drugs Sales by Application (2016-2026)
7.3 North America Intravenous (IV) Iron Drugs Market Size by Country
7.3.1 North America Intravenous (IV) Iron Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Intravenous (IV) Iron Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous (IV) Iron Drugs Sales by Type (2016-2026)
8.2 Europe Intravenous (IV) Iron Drugs Sales by Application (2016-2026)
8.3 Europe Intravenous (IV) Iron Drugs Market Size by Country
8.3.1 Europe Intravenous (IV) Iron Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Intravenous (IV) Iron Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Intravenous (IV) Iron Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Intravenous (IV) Iron Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Intravenous (IV) Iron Drugs Market Size by Region
9.3.1 Asia-Pacific Intravenous (IV) Iron Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Intravenous (IV) Iron Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Intravenous (IV) Iron Drugs Sales by Type (2016-2026)
10.2 South America Intravenous (IV) Iron Drugs Sales by Application (2016-2026)
10.3 South America Intravenous (IV) Iron Drugs Market Size by Country
10.3.1 South America Intravenous (IV) Iron Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Intravenous (IV) Iron Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Intravenous (IV) Iron Drugs Market Size by Country
11.3.1 Middle East & Africa Intravenous (IV) Iron Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Intravenous (IV) Iron Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Intravenous (IV) Iron Drugs Typical Distributors
12.3 Intravenous (IV) Iron Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Intravenous (IV) Iron Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Intravenous (IV) Iron Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi US Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi US Major Business
Table 5. Sanofi US Intravenous (IV) Iron Drugs Product and Services
Table 6. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Intravenous (IV) Iron Drugs Product and Services
Table 10. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. AMAG Pharmaceuticals Major Business
Table 13. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product and Services
Table 14. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Dalichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 16. Dalichi Sankyo Major Business
Table 17. Dalichi Sankyo Intravenous (IV) Iron Drugs Product and Services
Table 18. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Luitpold Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Luitpold Pharmaceuticals Major Business
Table 21. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product and Services
Table 22. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pharmacosmos Basic Information, Manufacturing Base and Competitors
Table 24. Pharmacosmos Major Business
Table 25. Pharmacosmos Intravenous (IV) Iron Drugs Product and Services
Table 26. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Takeda Pharmaceutical Major Business
Table 29. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product and Services
Table 30. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Intravenous (IV) Iron Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Intravenous (IV) Iron Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Intravenous (IV) Iron Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Intravenous (IV) Iron Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Intravenous (IV) Iron Drugs Production Site of Key Manufacturer
Table 36. Global Intravenous (IV) Iron Drugs Sales by Region (2016-2021e) & (K Units)
Table 37. Global Intravenous (IV) Iron Drugs Sales by Region (2021-2026) & (K Units)
Table 38. Global Intravenous (IV) Iron Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Intravenous (IV) Iron Drugs Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Intravenous (IV) Iron Drugs Sales by Type (2016-2021e) & (K Units)
Table 41. Global Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units)
Table 42. Global Intravenous (IV) Iron Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Intravenous (IV) Iron Drugs Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Intravenous (IV) Iron Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 45. Global Intravenous (IV) Iron Drugs Price by Type (2021-2026) & (USD/Unit)
Table 46. Global Intravenous (IV) Iron Drugs Sales by Application (2016-2021e) & (K Units)
Table 47. Global Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Global Intravenous (IV) Iron Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Intravenous (IV) Iron Drugs Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Intravenous (IV) Iron Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 51. Global Intravenous (IV) Iron Drugs Price by Application (2021-2026) & (USD/Unit)
Table 52. North America Intravenous (IV) Iron Drugs Sales by Country (2016-2021e) & (K Units)
Table 53. North America Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units)
Table 54. North America Intravenous (IV) Iron Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Intravenous (IV) Iron Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Intravenous (IV) Iron Drugs Sales by Type (2016-2021e) & (K Units)
Table 57. North America Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units)
Table 58. North America Intravenous (IV) Iron Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. North America Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Europe Intravenous (IV) Iron Drugs Sales by Country (2016-2021e) & (K Units)
Table 61. Europe Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units)
Table 62. Europe Intravenous (IV) Iron Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Intravenous (IV) Iron Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Intravenous (IV) Iron Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Europe Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Europe Intravenous (IV) Iron Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. Europe Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific Intravenous (IV) Iron Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Intravenous (IV) Iron Drugs Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units)
Table 76. South America Intravenous (IV) Iron Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. South America Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units)
Table 78. South America Intravenous (IV) Iron Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Intravenous (IV) Iron Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Intravenous (IV) Iron Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. South America Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units)
Table 82. South America Intravenous (IV) Iron Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. South America Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa Intravenous (IV) Iron Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Intravenous (IV) Iron Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Intravenous (IV) Iron Drugs Typical Distributors
Table 95. Intravenous (IV) Iron Drugs Typical Customers
List of Figures
Figure 1. Intravenous (IV) Iron Drugs Picture
Figure 2. Global Intravenous (IV) Iron Drugs Sales Market Share by Type in 2020
Figure 3. Ferric Carboxymaltose
Figure 4. Iron Sucrose
Figure 5. Iron Dextran
Figure 6. Others
Figure 7. Global Intravenous (IV) Iron Drugs Sales Market Share by Application in 2020
Figure 8. Nephrology
Figure 9. Gynecology & Obstetrics
Figure 10. Gastroenterology
Figure 11. Oncology
Figure 12. Cardiology
Figure 13. Others
Figure 14. Global Intravenous (IV) Iron Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Intravenous (IV) Iron Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Intravenous (IV) Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Intravenous (IV) Iron Drugs Sales (2016-2026) & (K Units)
Figure 36. Global Intravenous (IV) Iron Drugs Production Capacity (2016-2026) & (K Units)
Figure 37. Global Intravenous (IV) Iron Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Intravenous (IV) Iron Drugs Market Drivers
Figure 39. Intravenous (IV) Iron Drugs Market Restraints
Figure 40. Intravenous (IV) Iron Drugs Market Trends
Figure 41. Global Intravenous (IV) Iron Drugs Sales Market Share by Manufacturer in 2020
Figure 42. Global Intravenous (IV) Iron Drugs Revenue Market Share by Manufacturer in 2020
Figure 43. Intravenous (IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Intravenous (IV) Iron Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Intravenous (IV) Iron Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Intravenous (IV) Iron Drugs Sales Market Share by Region (2016-2026)
Figure 47. Global Intravenous (IV) Iron Drugs Revenue Market Share by Region (2016-2026)
Figure 48. North America Intravenous (IV) Iron Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Europe Intravenous (IV) Iron Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Intravenous (IV) Iron Drugs Revenue (2016-2026) & (USD Million)
Figure 51. South America Intravenous (IV) Iron Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Intravenous (IV) Iron Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Global Intravenous (IV) Iron Drugs Sales Market Share by Type (2016-2026)
Figure 54. Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2016-2026)
Figure 55. Global Intravenous (IV) Iron Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Intravenous (IV) Iron Drugs Sales Market Share by Application (2016-2026)
Figure 57. Global Intravenous (IV) Iron Drugs Revenue Market Share by Application (2016-2026)
Figure 58. Global Intravenous (IV) Iron Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Intravenous (IV) Iron Drugs Sales Market Share by Country (2016-2026)
Figure 60. North America Intravenous (IV) Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 61. North America Intravenous (IV) Iron Drugs Sales Market Share by Type (2016-2026)
Figure 62. North America Intravenous (IV) Iron Drugs Sales Market Share by Application (2016-2026)
Figure 63. Europe Intravenous (IV) Iron Drugs Sales Market Share by Country (2016-2026)
Figure 64. Europe Intravenous (IV) Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Europe Intravenous (IV) Iron Drugs Sales Market Share by Type (2016-2026)
Figure 66. Europe Intravenous (IV) Iron Drugs Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Intravenous (IV) Iron Drugs Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Intravenous (IV) Iron Drugs Sales Market Share by Country (2016-2026)
Figure 72. South America Intravenous (IV) Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 73. South America Intravenous (IV) Iron Drugs Sales Market Share by Type (2016-2026)
Figure 74. South America Intravenous (IV) Iron Drugs Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Intravenous (IV) Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

---